Summary
Further key aspects of the report indicate that:
Chapter 1: Research Scope: Product Definition, Type, End-Use & Methodology
Chapter 2: Global Industry Summary
Chapter 3: Market Dynamics
Chapter 4: Global Market Segmentation by region, type and End-Use
Chapter 5: North America Market Segmentation by region, type and End-Use
Chapter 6: Europe Market Segmentation by region, type and End-Use
Chapter 7: Asia-Pacific Market Segmentation by region, type and End-Use
Chapter 8: South America Market Segmentation by region, type and End-Use
Chapter 9: Middle East and Africa Market Segmentation by region, type and End-Use.
Chapter 10: Market Competition by Companies
Chapter 11: Market forecast and environment forecast.
Chapter 12: Industry Summary.
The global Influenza Medication market has the potential to grow with xx million USD with growing CAGR in the forecast period from 2021f to 2026f. Factors driving the market is expected to play significant role in the development of demand and improvement due to COVID-19..
Based on the type of product, the global Influenza Medication market segmented into
Zanamivir
Oseltamivir phosphate
Peramivir
Other Influenza Medication
Based on the end-use, the global Influenza Medication market classified into
adult
kids
Based on geography, the global Influenza Medication market segmented into
North America [U.S., Canada, Mexico]
Europe [Germany, UK, France, Italy, Rest of Europe]
Asia-Pacific [China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific]
South America [Brazil, Argentina, Rest of Latin America]
Middle East & Africa [GCC, North Africa, South Africa, Rest of Middle East and Africa]
And the major players included in the report are
Bristol-Myers Squibb
AstraZeneca
Eli Lilly
Roche
GSK
Novartis
Pfizer
Sanofi
Bayer
Celgene
Seqirus
End of Summary
Table of Contents
1 RESEARCH SCOPE
1.1 Research Product Definition
1.2 Research Segmentation
1.2.1 Product Type
1.2.2 Main product Type of Major Players
1.3 Demand Overview
1.4 Research Methodology
2 GLOBAL INFLUENZA MEDICATION INDUSTRY
2.1 Summary about Influenza Medication Industry
2.2 Influenza Medication Market Trends
2.2.1 Influenza Medication Production & Consumption Trends
2.2.2 Influenza Medication Demand Structure Trends
2.3 Influenza Medication Cost & Price
3 MARKET DYNAMICS
3.1 Manufacturing & Purchasing Behavior in 2020
3.2 Market Development under the Impact of COVID-19
3.2.1 Drivers
3.2.2 Restraints
3.2.3 Opportunity
3.2.4 Risk
4 GLOBAL MARKET SEGMENTATION
4.1 Region Segmentation (2017 to 2021f)
4.1.1 North America (U.S., Canada and Mexico)
4.1.2 Europe (Germany, UK, France, Italy, Rest of Europe)
4.1.3 Asia-Pacific (China, India, Japan, South Korea, Southeast Asia, Australia, Rest of Asia Pacific)
4.1.4 South America (Brazil,, Argentina, Rest of Latin America)
4.1.5 Middle East and Africa (GCC, North Africa, South Africa, Rest of Middle East and Africa)
4.2 Product Type Segmentation (2017 to 2021f)
4.2.1 Zanamivir
4.2.2 Oseltamivir phosphate
4.2.3 Peramivir
4.2.4 Other Influenza Medication
4.3 Consumption Segmentation (2017 to 2021f)
4.3.1 adult
4.3.2 kids
5 NORTH AMERICA MARKET SEGMENT
5.1 Region Segmentation (2017 to 2021f)
5.1.1 U.S.
5.1.2 Canada
5.1.3 Mexico
5.2 Product Type Segmentation (2017 to 2021f)
5.2.1 Zanamivir
5.2.2 Oseltamivir phosphate
5.2.3 Peramivir
5.2.4 Other Influenza Medication
5.3 Consumption Segmentation (2017 to 2021f)
5.3.1 adult
5.3.2 kids
5.4 Impact of COVID-19 in North America
6 EUROPE MARKET SEGMENTATION
6.1 Region Segmentation (2017 to 2021f)
6.1.1 Germany
6.1.2 UK
6.1.3 France
6.1.4 Italy
6.1.5 Rest of Europe
6.2 Product Type Segmentation (2017 to 2021f)
6.2.1 Zanamivir
6.2.2 Oseltamivir phosphate
6.2.3 Peramivir
6.2.4 Other Influenza Medication
6.3 Consumption Segmentation (2017 to 2021f)
6.3.1 adult
6.3.2 kids
6.4 Impact of COVID-19 in Europe
7 ASIA-PACIFIC MARKET SEGMENTATION
7.1 Region Segmentation (2017 to 2021f)
7.1.1 China
7.1.2 India
7.1.3 Japan
7.1.4 South Korea
7.1.5 Southeast Asia
7.1.6 Australia
7.1.7 Rest of Asia Pacific
7.2 Product Type Segmentation (2017 to 2021f)
7.2.1 Zanamivir
7.2.2 Oseltamivir phosphate
7.2.3 Peramivir
7.2.4 Other Influenza Medication
7.3 Consumption Segmentation (2017 to 2021f)
7.3.1 adult
7.3.2 kids
7.4 Impact of COVID-19 in Europe
8 SOUTH AMERICA MARKET SEGMENTATION
8.1 Region Segmentation (2017 to 2021f)
8.1.1 Brazil
8.1.2 Argentina
8.1.3 Rest of Latin America
8.2 Product Type Segmentation (2017 to 2021f)
8.2.1 Zanamivir
8.2.2 Oseltamivir phosphate
8.2.3 Peramivir
8.2.4 Other Influenza Medication
8.3 Consumption Segmentation (2017 to 2021f)
8.3.1 adult
8.3.2 kids
8.4 Impact of COVID-19 in Europe
9 MIDDLE EAST AND AFRICA MARKET SEGMENTATION
9.1 Region Segmentation (2017 to 2021f)
9.1.1 GCC
9.1.2 North Africa
9.1.3 South Africa
9.1.4 Rest of Middle East and Africa
9.2 Product Type Segmentation (2017 to 2021f)
9.2.1 Zanamivir
9.2.2 Oseltamivir phosphate
9.2.3 Peramivir
9.2.4 Other Influenza Medication
9.3 Consumption Segmentation (2017 to 2021f)
9.3.1 adult
9.3.2 kids
9.4 Impact of COVID-19 in Europe
10 COMPETITION OF MAJOR PLAYERS
10.1 Brief Introduction of Major Players
10.1.1 Bristol-Myers Squibb
10.1.2 AstraZeneca
10.1.3 Eli Lilly
10.1.4 Roche
10.1.5 GSK
10.1.6 Novartis
10.1.7 Pfizer
10.1.8 Sanofi
10.1.9 Bayer
10.1.10 Celgene
10.1.11 Seqirus
10.2 Influenza Medication Sales Date of Major Players (2017-2020e)
10.2.1 Bristol-Myers Squibb
10.2.2 AstraZeneca
10.2.3 Eli Lilly
10.2.4 Roche
10.2.5 GSK
10.2.6 Novartis
10.2.7 Pfizer
10.2.8 Sanofi
10.2.9 Bayer
10.2.10 Celgene
10.2.11 Seqirus
10.3 Market Distribution of Major Players
10.4 Global Competition Segmentation
11 MARKET FORECAST
11.1 Forecast by Region
11.2 Forecast by Demand
11.3 Environment Forecast
11.3.1 Impact of COVID-19
11.3.2 Geopolitics Overview
11.3.3 Economic Overview of Major Countries
12 REPORT SUMMARY STATEMENT
List of Tables and Figures
List of Table
1.Table Influenza Medication Product Type Overview
2.Table Influenza Medication Product Type Market Share List
3.Table Influenza Medication Product Type of Major Players
4.Table Brief Introduction of Bristol-Myers Squibb
5.Table Brief Introduction of AstraZeneca
6.Table Brief Introduction of Eli Lilly
7.Table Brief Introduction of Roche
8.Table Brief Introduction of GSK
9.Table Brief Introduction of Novartis
10.Table Brief Introduction of Pfizer
11.Table Brief Introduction of Sanofi
12.Table Brief Introduction of Bayer
13.Table Brief Introduction of Celgene
14.Table Brief Introduction of Seqirus
15.Table Products & Services of Bristol-Myers Squibb
16.Table Products & Services of AstraZeneca
17.Table Products & Services of Eli Lilly
18.Table Products & Services of Roche
19.Table Products & Services of GSK
20.Table Products & Services of Novartis
21.Table Products & Services of Pfizer
22.Table Products & Services of Sanofi
23.Table Products & Services of Bayer
24.Table Products & Services of Celgene
25.Table Products & Services of Seqirus
26.Table Market Distribution of Major Players
27.Table Global Major Players Sales Revenue (Million USD) 2017-2020e
28.Table Global Major Players Sales Revenue (Million USD) Share 2017-2020e
29.Table Global Influenza Medication Market Forecast (Million USD) by Region 2021f-2026f
30.Table Global Influenza Medication Market Forecast (Million USD) Share by Region 2021f-2026f
31.Table Global Influenza Medication Market Forecast (Million USD) by Demand 2021f-2026f
32.Table Global Influenza Medication Market Forecast (Million USD) Share by Demand 2021f-2026f
List of Figure
1.Figure Global Influenza Medication Market Size under the Impact of COVID-19, 2017-2021f (USD Million)
2.Figure Global Influenza Medication Market by Region under the Impact of COVID-19, 2017-2021f (USD Million)
3.Figure Global Influenza Medication Market by Product Type under the Impact of COVID-19, 2017-2021f (USD Million)
4.Figure Global Influenza Medication Market by Demand under the Impact of COVID-19, 2017-2021f (USD Million)
5.Figure Global Influenza Medication Production by Region under the Impact of COVID-19, 2021-2026 (USD Million)
6.Figure Global Influenza Medication Consumption by Region under the Impact of COVID-19, 2021-2026 (USD Million)
7.Figure Global Influenza Medication Consumption by Type under the Impact of COVID-19, 2021-2026 (USD Million)
8.Figure North America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
9.Figure Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
10.Figure Asia-Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
11.Figure South America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
12.Figure Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
13.Figure Zanamivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
14.Figure Oseltamivir phosphate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
15.Figure Peramivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
16.Figure Other Influenza Medication Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
17.Figure adult Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
18.Figure kids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
19.Figure U.S. Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
20.Figure Canada Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
21.Figure Mexico Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
22.Figure Zanamivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
23.Figure Oseltamivir phosphate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
24.Figure Peramivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
25.Figure Other Influenza Medication Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
26.Figure adult Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
27.Figure kids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
28.Figure Germany Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
29.Figure UK Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
30.Figure France Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
31.Figure Italy Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
32.Figure Rest of Europe Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
33.Figure Zanamivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
34.Figure Oseltamivir phosphate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
35.Figure Peramivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
36.Figure Other Influenza Medication Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
37.Figure adult Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
38.Figure kids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
39.Figure China Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
40.Figure India Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
41.Figure Japan Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
42.Figure South Korea Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
43.Figure Southeast Asia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
44.Figure Australia Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
45.Figure Rest of Asia Pacific Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
46.Figure Zanamivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
47.Figure Oseltamivir phosphate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
48.Figure Peramivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
49.Figure Other Influenza Medication Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
50.Figure adult Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
51.Figure kids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
52.Figure Brazil Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
53.Figure Argentina Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
54.Figure Rest of Latin America Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
55.Figure Zanamivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
56.Figure Oseltamivir phosphate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
57.Figure Peramivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
58.Figure Other Influenza Medication Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
59.Figure adult Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
60.Figure kids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
61.Figure GCC Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
62.Figure North Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
63.Figure South Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
64.Figure Rest of Middle East and Africa Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
65.Figure Zanamivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
66.Figure Oseltamivir phosphate Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
67.Figure Peramivir Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
68.Figure Other Influenza Medication Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
69.Figure adult Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
70.Figure kids Segmentation Market Size (USD Million) 2017-2021f and Year-over-year (YOY) Growth (%) 2018-2021f
71.Figure Influenza Medication Sales Revenue (Million USD) of Bristol-Myers Squibb 2017-2020e
72.Figure Influenza Medication Sales Revenue (Million USD) of AstraZeneca 2017-2020e
73.Figure Influenza Medication Sales Revenue (Million USD) of Eli Lilly 2017-2020e
74.Figure Influenza Medication Sales Revenue (Million USD) of Roche 2017-2020e
75.Figure Influenza Medication Sales Revenue (Million USD) of GSK 2017-2020e
76.Figure Influenza Medication Sales Revenue (Million USD) of Novartis 2017-